Split-course accelerated hyperfractionated irradiation (CHA-CHA) as a sole treatment for advanced head and neck cancer patients—final results of a randomized clinical trial

Abstract

Obtained results in the context of published data support the statement that altered fractionations alone do not give an advantage for advanced H&N cancer patients.